TAO Synergies TAOX
NASDAQ TAOX
$4.39 -0.14 (-3.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

TAO Synergies (TAOX) Liabilities and Shareholders Equity (2019 - 2026)

Updated

TAO Synergies (TAOX) posted Liabilities and Shareholders Equity of $21.1 million for Q2 2026, up 6.6% from $19.79 million a year earlier but down 32.0% from the prior quarter.

Analysis

TAO Synergies (TAOX) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, TAO Synergies' Liabilities and Shareholders Equity came in at $25.84 million, up 45.7% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 30.8% (FY2020 to FY2025).
  • In prior years, TAO Synergies' Liabilities and Shareholders Equity was $17.73 million in FY2024 (-43.0%), $31.11 million in FY2023 (-19.4%), $38.61 million in FY2022 (+8.7%) and $35.52 million in FY2021 (+426.2%).
  • Quarterly Liabilities and Shareholders Equity has run from a low of $15.33 million in Q1 2025 to a high of $38.61 million in Q4 2022 over five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last three quarters, with an average decline of 1.9% over the last eight quarters.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q4 2021, with growth of 426.2%; the weakest was Q1 2025, with a decline of 47.9%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $31.05 million (Q1 2026), $25.84 million (Q4 2025) and $18.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 TAO Synergies 33.85 Mn 33.85 Mn - 21.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.10 Mn
Mar 31, 2026 31.05 Mn
Dec 31, 2025 25.84 Mn
Sep 30, 2025 18.36 Mn
Jun 30, 2025 19.79 Mn
Mar 31, 2025 15.33 Mn
Dec 31, 2024 17.73 Mn
Sep 30, 2024 22.83 Mn
Jun 30, 2024 28.39 Mn
Mar 31, 2024 29.40 Mn
Dec 31, 2023 31.11 Mn
Sep 30, 2023 32.36 Mn
Jun 30, 2023 33.44 Mn
Mar 31, 2023 36.53 Mn
Dec 31, 2022 38.61 Mn
Sep 30, 2022 27.35 Mn
Jun 30, 2022 29.58 Mn
Mar 31, 2022 32.35 Mn
Dec 31, 2021 35.52 Mn
Sep 30, 2021 32.36 Mn
API Access

TAO Synergies Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TAOX&period=max&api_key=YOUR_API_KEY